Clinical trial
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
NCT02886897
Study timeline
Study start (unknown)2016-07-01Date precision: month
Registry last updated2016-09-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hepatocellular Carcinomaunresolved
Renal Cell Carcinomaunresolved
Bladder Cancerunresolved
Colorectal Cancerunresolved
Non-small-cell Lung Cancerunresolved
Breast Cancerunresolved
Interventions
D-CIK and anti-PD-1 antibodyBIOLOGICAL
Sponsors & collaborators
Sun Yat-sen Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02886897 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.